Background Pharmacogenomic clinical decision support systems (CDSS) have the potential
to help overcome some of the barriers for translating pharmacogenomic knowledge into …

Objective: To develop a systematic set of German cost data in rheumatoid arthritis (RA) based
solely on valid healthcare payer’s cost data sources. Methods: Retrospectively one year …

Methods In a two-year prospective cohort study 320 patients with rheumatic symptoms of less
than one year were investigated in an early synovitis out-patient clinic. Besides the clinical …

The aim of our review was to examine recently published cost-evaluations presenting originally
developed data in rheumatic conditions. We identified 21 articles: 9 presenting original …

Early arthritis is challenging because the clinical picture often does not allow a distinction
between rheumatoid arthritis (RA), self-limiting disease, and other forms of inflammatory …

OBJECTIVE To evaluate the diagnostic performance of classification criteria for rheumatoid
arthritis (RA) and reactive arthritis (ReA) in an early synovitis outpatient clinic. METHODS In …

Diagnosis of arthritis with recent onset is still an unresolved problem. In 1984 we started an
outpatient clinic for patients with early arthritis of less than one year duration. Of a total of 226 …

The objective of this study is to review the concept of the ‘Hannover Costing Study’ and to
present and discuss the major insights generated during the course of the project. The costing …

OBJECTIVE: To determine how experts would classify 10 early-arthritis cases (7 atypical) and
to study discrepancies in diagnoses relative to ACR criteria for rheumatoid arthritis (RA) or …

Accurate estimation of medical care costs raises a host of challenging issues. We examined
whether pure administrative claims data without clinical validation of diagnosis allow …